Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$9.97M Sell
176,273
-1,458
-0.8% -$81.9K 0.56% 49
2014
Q2
$9.81M Buy
177,731
+5,400
+3% +$295K 0.55% 51
2014
Q1
$9.34M Sell
172,331
-5,528
-3% -$286K 0.58% 48
2013
Q4
$8.49M Sell
177,859
-10,578
-6% -$484K 0.56% 52
2013
Q3
$8.56M Buy
188,437
+1,549
+0.8% +$70.7K 0.68% 41
2013
Q2
$8.28M Buy
+186,888
New +$8.35M 0.66% 41

Other funds holding MRK

McAdams Wright Ragen's MRK Position: Q3 2014 in Review

McAdams Wright Ragen reduced its Merck (MRK) stake by 0.82% in Q3 2014, selling an estimated $81.9K and leaving 176,273 shares worth $9.97M. The position accounts for 0.56% of the portfolio, ranked #49.

McAdams Wright Ragen first reported a position in MRK in Q2 2013 and has held it in 6 quarters since. 1,617 funds tracked by Wall St. Rank hold MRK as of Q3 2014.

  • McAdams Wright Ragen held 176,273 shares of Merck worth $9.97M as of Q3 2014.
  • McAdams Wright Ragen sold 1,458 Merck shares in Q3 2014, an estimated $81.9K.
  • Merck made up 0.56% of McAdams Wright Ragen's portfolio in Q3 2014, its #49 holding.
  • McAdams Wright Ragen first reported a position in Merck in Q2 2013 and has held it in 6 quarters since.
  • 1,617 funds tracked by Wall St. Rank held Merck as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.